Overview

Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether magnesium preloading reduce incident of cisplatin induced acute kidney injury in head and neck cancer who receiving low dose cisplatin (40 mg/m2 weekly for 7 weeks).

Phase:

Phase 4

Details

Lead Sponsor:

Mahidol University

Treatments:

Cisplatin